Once children in those locations have good recovery of CD4 T cells during ART, the
risk of opportunistic infections is low and cessation of co-trimoxazole appears to be safe. However, we found that co-trimoxazole continues to provide protection against bacterial infections and malaria in sub-Saharan Africa, despite good
immune reconstitution during long-term ART.